Michael Hallek to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications Michael Hallek has written about Xenograft Model Antitumor Assays.
Connection Strength
0.039
-
A combination of low-dose bevacizumab and imatinib enhances vascular normalisation without inducing extracellular matrix deposition. Br J Cancer. 2017 Feb 28; 116(5):600-608.
Score: 0.039
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.